Role of dexmedetomidineas an analgesic in muscle pain in electro convulsive therapy
Not Applicable
Completed
- Conditions
- Health Condition 1: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
- Registration Number
- CTRI/2021/10/037656
- Lead Sponsor
- IMS AND SUM HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
ASA-1, 2, age 18 - 65 years, Electroconvulsive therapy.
Exclusion Criteria
ASA- Class 3 or higher, uncontrolled hypertension, patients with a poor cardiopulmonary reserve and with body mass index (BMI) >30 kg/m2, renal failure, decompensated cirrhosis, being pregnant, or refusal to provide written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method